Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent

Nephrology Dialysis Transplantation

Volumn 28, Issue 8, 2013, Pages 2015-2027

  Margetts, Peter J ^a   Hoff, Catherine ^b   Liu, Limin ^a   Korstanje, Ron ^c   Walkin, Louise ^d   Summers, Angela ^d   Herrick, Sarah ^e   Brenchley, Paul ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c JACKSON LABORATORY   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adenovirus; Angiogenesis; Genetics; Peritoneal dialysis; Peritoneal membrane

Indexed keywords

COLLAGEN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C3H/HE MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DBA 2 MOUSE; DISEASE PREDISPOSITION; GENE EXPRESSION; MALE; MOLECULAR PATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; SWISS JAMES LAMBERT MOUSE; TRANSFORMING GROWTH FACTOR BETA GENE;

ADENOVIRUS; ANGIOGENESIS; GENETICS; PERITONEAL DIALYSIS; PERITONEAL MEMBRANE;

ANIMALS; INJECTIONS, INTRAPERITONEAL; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; SMAD PROTEINS; SPECIES SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884568759     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs289     Document Type: Article

References (39)

1. Brown MC, Simpson K, Kerssens JJ et al. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 2009; 4: 1222-1229
2. Johnson DW, Cho Y, Livingston BE et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int 2010; 77: 904-912
3. Balasubramaniam G, Brown EA, Davenport A et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2009; 24: 3209-3215
4. Yamamoto R, Otsuka Y, Nakayama M et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol 2005; 9: 148-152
5. Habib AM, Preston E, Davenport A. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant 2010; 25: 1633-1638
6. Lambie ML, John B, Mushahar L et al. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int 2010; 78: 611-618
7. Parikova A, Smit W, Struijk DG et al. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 2006; 70: 1988-1994
8. Lai KN, Lai KB, Szeto CC et al. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes. Am J Nephrol 1999; 19: 416-422
9. Gangji AS, Brimble KS, Margetts PJ. Association between markers of inflammation, fibrosis and hypervolemia in peritoneal dialysis patients. Blood Purif 2009; 28: 354-358
10. Margetts PJ, Kolb M, Galt T et al. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-2039
11. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
12. Margetts PJ, Bonniaud P, Liu L et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16: 425-436
13. Liu L, Shi CX, Ghayur A et al. Prolonged peritoneal gene expression using a helper-dependent adenovirus. Perit Dial Int 2009; 29: 508-516
14. Bonniaud P, Kolb M, Galt T et al. SMAD3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004; 173: 2099-2108
15. Patel P, Sekiguchi Y, Oh KH et al. SMAD3-dependent and-independent pathways are involved in peritoneal membrane injury. Kidney Int 2010; 77: 319-328
16. Maruyama Y, Numata M, Nakayama M et al. Relationship between the-374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis. Ther Apher Dial 2007; 11: 301-305
17. Gillerot G, Goffin E, Michel C et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487
18. Gewaltig J, Mangasser-Stephan K, Gartung C et al. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 2002; 316: 83-94
19. Powell EE, Edwards-Smith CJ, Hay JL et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-833
20. Hold GL, Untiveros P, Saunders KA et al. Role of host genetics in fibrosis. Fibrogenesis Tissue Repair 2009; 2: 6
21. Kolb M, Bonniaud P, Galt T et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of 'fibrosis-prone' and 'fibrosis-resistant' mouse strains. Am J Respir Cell Mol Biol 2002; 27: 141-150
22. Masinde GL, Li X, Gu W et al. Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res 2001; 11: 2027-2033
23. Safaeian L, Jafarian A, Rabbani M et al. The role of strain variation in BAX and BCL-2 expression in murine bleomycininduced pulmonary fibrosis. Pak J Biol Sci 2008; 11: 2606-2612
24. Haston CK, Begin M, Dorion G et al. Distinct loci influence radiation-induced alveolitis from fibrosing alveolitis in the mouse. Cancer Res 2007; 67: 10796-10803
25. Leelahavanichkul A, Yan Q, Hu X et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 2010; 78: 1136-1153
26. Hillebrandt S, Goos C, Matern S et al. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 2002; 123: 2041-2051
27. van den Borne SW, van de Schans VA, Strzelecka AE et al. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res 2009; 84: 273-282
28. Patel P, West-Mays J, Kolb M et al. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells. Matrix Biol 2010; 29: 97-106
29. Bonniaud P, Martin G, Margetts PJ et al. CTGF is crucial to induce a profibrotic environment in 'fibrosis resistant' BALB/c mouse lungs. Am J Respir Cell Mol Biol 2004; 31: 510-516
30. Rigg AS, Lemoine NR. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo. Cancer Gene Ther 2001; 8: 869-878
31. Mitchell CA, McGeachie JK, Grounds MD. Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and BALB/c mice. Cell Tissue Res 1992; 269: 159-166
32. Dal Canto MC, Melvold RW, Kim BS et al. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 1995; 32: 215-229
33. Paigen B, Ishida BY, Verstuyft J et al. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 1990; 10: 316-323
34. Yu H, Baylink DJ, Masinde GL et al. Mouse chromosome 9 quantitative trait loci for soft tissue regeneration: congenic analysis and fine mapping. Wound Repair Regen 2007; 15: 922-927
35. Cho HJ, Baek KE, Saika S et al. snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007; 353: 337-343
36. Xie L, Law BK, Chytil AM et al. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 2004; 6: 603-610
37. Mateijsen MA, van der Wal AC, Hendriks PM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525
38. De Vriese AS, Tilton RG, Stephan CC et al. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12: 1734-1741
39. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-948